Ford AC, Wright-Hughes A, Alderson SL, Ow PL, et al. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023 Oct 16:S0140-6736(23)01523-4. doi: 10.1016/S0140-6736(23)01523.
PMID: 37858323